title: Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice.
abstract: Oral administration of maize-expressed H3N2 nucleoprotein induced antibody responses in mice showing the immunogenicity of plant-derived antigen and its potential to be utilized as a universal flu vaccine. Influenza A viruses cause influenza epidemics that are devastating to humans and livestock. The vaccine for influenza needs to be reformulated every year to match the circulating strains due to virus mutation. Influenza virus nucleoprotein (NP) is a multifunctional RNA-binding protein that is highly conserved among strains, making it a potential candidate for a universal vaccine. In this study, the NP gene of H3N2 swine origin influenza virus was expressed in maize endosperm. Twelve transgenic maize lines were generated and analyzed for recombinant NP (rNP) expression. Transcript analysis showed the main accumulation of rNP in seed. Protein level of rNP in T1 transgenic maize seeds ranged from 8.0 to 35 µg of NP/g of corn seed. The level increased up to 70 µg of NP/g in T3 seeds. A mouse study was performed to test the immunogenicity of one line of maize-derived rNP (MNP). Mice were immunized with MNP in a prime-boost design. Oral gavage administration showed that a humoral immune response was elicited in the mice treated with MNP indicating the immunogenicity of MNP. NP-specific antibody responses in the MNP group showed comparable antibody titer with the groups receiving positive controls such as Vero cell-derived NP (VNP) or alphavirus replicon particle-derived NP (ANP). Cytokine analysis showed antigen-specific stimulation of IL-4 cytokine elicited in splenocytes from mice treated with MNP further confirming a TH2 humoral immune response induced by MNP administration.
authors: Interdepartmental Plant Biology Major, Iowa State University, Ames, IA, 50011-1010, USA.
authors: Hartinio N
authors: HN
authors: Nahampun
authors: Brad
authors: B
authors: Bosworth
authors: Joan
authors: J
authors: Cunnick
authors: Mark
authors: M
authors: Mogler
authors: Kan
authors: K
authors: Wang
mesh_terms: D000284:Administration, Oral; D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D053122:Influenza A Virus, H3N2 Subtype / Q000737:chemistry* / Q000472:pathogenicity; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D008807:Mice, Inbred BALB C; D019590:Nucleocapsid Proteins; D030821:Plants, Genetically Modified; D016601:RNA-Binding Proteins / Q000235:genetics* / Q000276:immunology*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D012639:Seeds / Q000235:genetics / Q000378:metabolism; D034421:Sus scrofa; D014758:Viral Core Proteins / Q000235:genetics* / Q000276:immunology*; D003313:Zea mays / Q000235:genetics* / Q000378:metabolism
chemical_list: D007252:Influenza Vaccines; C048842:NP protein, Influenza A virus; D019590:Nucleocapsid Proteins; D016601:RNA-Binding Proteins; D011994:Recombinant Proteins; D014758:Viral Core Proteins